Literature DB >> 9518949

Managing the patient with hard-to-control hypertension.

S Oparil1, D A Calhoun.   

Abstract

Less than 25 percent of patients with hypertension in the United States have their blood pressure under control, mainly because of inadequate or inappropriate therapy and noncompliance. Approximately one half of these treatment failures are related to factors such as cost and adverse effects of medication, complex drug regimens, failure of clinicians to fully realize the benefits of antihypertensive therapy and lack of patient education. Other major causes of unresponsiveness to antihypertensive therapy include "white coat" hypertension, pseudohypertension, obesity, volume overload, excess alcohol intake and sleep apnea, as well as inappropriate antihypertensive drugs and drug combinations, and unfavorable interactions with prescription and other drugs. In many patients, these factors must be dealt with before blood pressure can be controlled.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9518949

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  7 in total

Review 1.  Evidence based management of hypertension: What to do when blood pressure is difficult to control.

Authors:  J E O'Rorke; W S Richardson
Journal:  BMJ       Date:  2001-05-19

2.  Risk of acute myocardial infarction after discontinuation of antihypertensive agents: a case-control study.

Authors:  F F Alharbi; P C Souverein; M C de Groot; A H Maitland-van der Zee; A de Boer; O H Klungel
Journal:  J Hum Hypertens       Date:  2017-03-23       Impact factor: 3.012

3.  Symptoms of depression and anxiety and adherence to antihypertensive medication.

Authors:  Leonelo E Bautista; Lina M Vera-Cala; Cynthia Colombo; Paul Smith
Journal:  Am J Hypertens       Date:  2012-01-19       Impact factor: 2.689

4.  Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors.

Authors:  Philip S Wang; Rhonda L Bohn; Eric Knight; Robert J Glynn; Helen Mogun; Jerry Avorn
Journal:  J Gen Intern Med       Date:  2002-07       Impact factor: 5.128

5.  Diseases of poverty and lifestyle, well-being and human development.

Authors:  Ajai R Singh; Shakuntala A Singh
Journal:  Mens Sana Monogr       Date:  2008-01

6.  Intensive monitoring of adherence to treatment helps to identify "true" resistant hypertension.

Authors:  Walnéia Aparecida de Souza; Maricene Sabha; Fabrício de Faveri Favero; Gun Bergsten-Mendes; Juan Carlos Yugar-Toledo; Heitor Moreno
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-04       Impact factor: 3.738

Review 7.  Compliance and fixed-dose combination therapy.

Authors:  Sripal Bangalore; Anupama Shahane; Sanobar Parkar; Franz H Messerli
Journal:  Curr Hypertens Rep       Date:  2007-06       Impact factor: 4.592

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.